Phibro Animal Health reported $570.08M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US USD 2.42B 76.19M
Ani Pharmaceuticals ANIP:US USD 309.38M 13.02M
Aurora Cannabis Inc ACB:CN CAD 681.83M 63.29M
Canopy Growth Corp WEED:CN CAD 1.54B 55.4M
Corcept Therapeutics CORT:US USD 452.4M 33.36M
Depomed DEPO:US USD 126.49M 9.8M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Henry Schein HSIC:US USD 3.96B 168M
Idexx Laboratories IDXX:US USD 1.06B 16.03M
Knight Therapeutics Inc GUD:CN CAD 342.85M 22.5M
Lannett LCI:US USD 250.53M 14.13M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Patterson Companies PDCO:US USD 1.83B 119.55M
Phibro Animal Health PAHC:US USD 570.08M 3.85M
Prestige Brands PBH:US USD 408.85M 72.19M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Zoetis ZTS:US USD 6.55B 100M